111

ABCLON INC.

No trades
See on Supercharts

174900 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

AbClon, Inc. engages in the development, manufacture and sale of antibody drugs. It operates through the Therapeutic antibody and Bio CRO businesses. Its offers antibodies and detection kits. The company was founded by Carl Erik Mathias Uhlén and Jong-Seo Lee on June 25, 2010 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

174900 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company